Literature DB >> 1311566

Induction of Mn-superoxide dismutase by tumor necrosis factor, interleukin-1 and interleukin-6 in human hepatoma cells.

M Ono1, H Kohda, T Kawaguchi, M Ohhira, C Sekiya, M Namiki, A Takeyasu, N Taniguchi.   

Abstract

Effects of Tumor Necrosis Factor (TNF), Interleukin-1 (IL-1), Interleukin-6 (IL-6) and Interferon-gamma (IFN-gamma) on the expression of Mn-superoxide dismutase (Mn-SOD) protein were investigated in human hepatoma cells, Hu-H1, which revealed resistance to the cytotoxicity of TNF and IL-1. Both TNF and IL-1 enhanced the Mn-SOD production to the level of 30- to 40-fold. IL-6 also increased the enzyme protein to 2- to 3-fold of the basal level without any cell proliferative effect. A specific antibody against IL-6 almost completely inhibited the induction of Mn-SOD. IL-6, as well as TNF and IL-1, appears to play some role in the Mn-SOD protein expression in human hepatoma cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311566     DOI: 10.1016/0006-291x(92)91845-h

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.

Authors:  Apollina Goel; Douglas R Spitz; George J Weiner
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

2.  Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation.

Authors:  A B Waxman; O Einarsson; T Seres; R G Knickelbein; J B Warshaw; R Johnston; R J Homer; J A Elias
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 3.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

4.  Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells.

Authors:  Kathryn E Hamilton; James G Simmons; Shengli Ding; Laurianne Van Landeghem; P Kay Lund
Journal:  Mol Cancer Res       Date:  2011-10-12       Impact factor: 5.852

5.  Induction of manganese superoxide dismutase mRNA by okadaic acid and protein synthesis inhibitors.

Authors:  J Fujii; T Nakata; E Miyoshi; Y Ikeda; N Taniguchi
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

6.  Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.

Authors:  Olaf Merkel; Christoph Heyder; Daniela Asslaber; Frank Hamacher; Inge Tinhofer; Claudia Holler; Markus Stöcher; Andreas Prokesch; Christine Papak; Marcel Scheideler; Zlatko Trajanoski; Richard Greil
Journal:  J Mol Med (Berl)       Date:  2008-02-23       Impact factor: 4.599

7.  Cancer cell-derived IL-1alpha induces IL-8 release in endothelial cells.

Authors:  Jung-Hyo Rhim; Sin-Ae Kim; Ji-Eun Lee; Dong-Jo Kim; Hong Keun Chung; Kum-Joo Shin; Junho Chung
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-11       Impact factor: 4.553

8.  Age-dependent dichotomous effect of superoxide dismutase Ala16Val polymorphism on oxidized LDL levels.

Authors:  George V Dedoussis; Stavroula Kanoni; Demosthenes B Panagiotakos; Eirini Louizou; Efi Grigoriou; Christina Chrysohoou; Christos Pitsavos; Christodoulos Stefanadis
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

9.  Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor.

Authors:  M T Vogels; W M Eling; A Otten; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

10.  Signal transducer and activator of transcription-3 mediated neuroprotective effect of interleukin-6 on cobalt chloride mimetic hypoxic cell death in R28 cells.

Authors:  Nanamika Thakur; Rajeev Kumar Pandey; Sanjana Mehrotra
Journal:  Mol Biol Rep       Date:  2021-07-27       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.